Cargando…
Recent Overview of the Use of iPSCs Huntington’s Disease Modeling and Therapy
Huntington’s disease (HD) is an inherited, autosomal dominant, degenerative disease characterized by involuntary movements, cognitive decline, and behavioral impairment ending in death. HD is caused by an expansion in the number of CAG repeats in the huntingtin gene on chromosome 4. To date, no effe...
Autores principales: | Csobonyeiova, Maria, Polak, Stefan, Danisovic, Lubos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139425/ https://www.ncbi.nlm.nih.gov/pubmed/32213859 http://dx.doi.org/10.3390/ijms21062239 |
Ejemplares similares
-
iPSCs in Modeling and Therapy of Osteoarthritis
por: Csobonyeiova, Maria, et al.
Publicado: (2021) -
Induced pluripotent stem cells for modeling and cell therapy of Parkinson's disease
por: Csöbönyeiová, Mária, et al.
Publicado: (2016) -
iPS cell technologies and their prospect for bone regeneration and disease modeling: A mini review
por: Csobonyeiova, Maria, et al.
Publicado: (2017) -
Recent Progress in the Regeneration of Spinal Cord Injuries by Induced Pluripotent Stem Cells
por: Csobonyeiova, Maria, et al.
Publicado: (2019) -
Induced Pluripotent Stem Cells for Duchenne Muscular Dystrophy Modeling and Therapy
por: Danisovic, Lubos, et al.
Publicado: (2018)